Index
1 δ-Valerolactone Market Overview
    1.1 δ-Valerolactone Product Overview
    1.2 δ-Valerolactone Market Segment by Type
        1.2.1 Assay: 98%
        1.2.2 Assay: 99%
    1.3 Global δ-Valerolactone Market Size by Type
        1.3.1 Global δ-Valerolactone Market Size Overview by Type (2018-2029)
        1.3.2 Global δ-Valerolactone Historic Market Size Review by Type (2018-2023)
        1.3.3 Global δ-Valerolactone Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America δ-Valerolactone Sales Breakdown by Type (2018-2023)
        1.4.2 Europe δ-Valerolactone Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific δ-Valerolactone Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America δ-Valerolactone Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa δ-Valerolactone Sales Breakdown by Type (2018-2023)
2 Global δ-Valerolactone Market Competition by Company
    2.1 Global Top Players by δ-Valerolactone Sales (2018-2023)
    2.2 Global Top Players by δ-Valerolactone Revenue (2018-2023)
    2.3 Global Top Players by δ-Valerolactone Price (2018-2023)
    2.4 Global Top Manufacturers δ-Valerolactone Manufacturing Base Distribution, Sales Area, Product Type
    2.5 δ-Valerolactone Market Competitive Situation and Trends
        2.5.1 δ-Valerolactone Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by δ-Valerolactone Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in δ-Valerolactone as of 2022)
    2.7 Date of Key Manufacturers Enter into δ-Valerolactone Market
    2.8 Key Manufacturers δ-Valerolactone Product Offered
    2.9 Mergers & Acquisitions, Expansion
3 δ-Valerolactone Status and Outlook by Region
    3.1 Global δ-Valerolactone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global δ-Valerolactone Historic Market Size by Region
        3.2.1 Global δ-Valerolactone Sales in Volume by Region (2018-2023)
        3.2.2 Global δ-Valerolactone Sales in Value by Region (2018-2023)
        3.2.3 Global δ-Valerolactone Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global δ-Valerolactone Forecasted Market Size by Region
        3.3.1 Global δ-Valerolactone Sales in Volume by Region (2024-2029)
        3.3.2 Global δ-Valerolactone Sales in Value by Region (2024-2029)
        3.3.3 Global δ-Valerolactone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global δ-Valerolactone by Application
    4.1 δ-Valerolactone Market Segment by Application
        4.1.1 Coatings, Adhesives, Resin Additives
        4.1.2 Pharmaceutical and Agrochemical Intermediates
    4.2 Global δ-Valerolactone Market Size by Application
        4.2.1 Global δ-Valerolactone Market Size Overview by Application (2018-2029)
        4.2.2 Global δ-Valerolactone Historic Market Size Review by Application (2018-2023)
        4.2.3 Global δ-Valerolactone Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America δ-Valerolactone Sales Breakdown by Application (2018-2023)
        4.3.2 Europe δ-Valerolactone Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific δ-Valerolactone Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America δ-Valerolactone Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa δ-Valerolactone Sales Breakdown by Application (2018-2023)
5 North America δ-Valerolactone by Country
    5.1 North America δ-Valerolactone Historic Market Size by Country
        5.1.1 North America δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America δ-Valerolactone Sales in Volume by Country (2018-2023)
        5.1.3 North America δ-Valerolactone Sales in Value by Country (2018-2023)
    5.2 North America δ-Valerolactone Forecasted Market Size by Country
        5.2.1 North America δ-Valerolactone Sales in Volume by Country (2024-2029)
        5.2.2 North America δ-Valerolactone Sales in Value by Country (2024-2029)
6 Europe δ-Valerolactone by Country
    6.1 Europe δ-Valerolactone Historic Market Size by Country
        6.1.1 Europe δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe δ-Valerolactone Sales in Volume by Country (2018-2023)
        6.1.3 Europe δ-Valerolactone Sales in Value by Country (2018-2023)
    6.2 Europe δ-Valerolactone Forecasted Market Size by Country
        6.2.1 Europe δ-Valerolactone Sales in Volume by Country (2024-2029)
        6.2.2 Europe δ-Valerolactone Sales in Value by Country (2024-2029)
7 Asia-Pacific δ-Valerolactone by Region
    7.1 Asia-Pacific δ-Valerolactone Historic Market Size by Region
        7.1.1 Asia-Pacific δ-Valerolactone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific δ-Valerolactone Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific δ-Valerolactone Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific δ-Valerolactone Forecasted Market Size by Region
        7.2.1 Asia-Pacific δ-Valerolactone Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific δ-Valerolactone Sales in Value by Region (2024-2029)
8 Latin America δ-Valerolactone by Country
    8.1 Latin America δ-Valerolactone Historic Market Size by Country
        8.1.1 Latin America δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America δ-Valerolactone Sales in Volume by Country (2018-2023)
        8.1.3 Latin America δ-Valerolactone Sales in Value by Country (2018-2023)
    8.2 Latin America δ-Valerolactone Forecasted Market Size by Country
        8.2.1 Latin America δ-Valerolactone Sales in Volume by Country (2024-2029)
        8.2.2 Latin America δ-Valerolactone Sales in Value by Country (2024-2029)
9 Middle East and Africa δ-Valerolactone by Country
    9.1 Middle East and Africa δ-Valerolactone Historic Market Size by Country
        9.1.1 Middle East and Africa δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa δ-Valerolactone Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa δ-Valerolactone Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa δ-Valerolactone Forecasted Market Size by Country
        9.2.1 Middle East and Africa δ-Valerolactone Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa δ-Valerolactone Sales in Value by Country (2024-2029)
10 Company Profiles
    10.1 BASF
        10.1.1 BASF Company Information
        10.1.2 BASF Introduction and Business Overview
        10.1.3 BASF δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 BASF δ-Valerolactone Products Offered
        10.1.5 BASF Recent Development
    10.2 Ube Industries
        10.2.1 Ube Industries Company Information
        10.2.2 Ube Industries Introduction and Business Overview
        10.2.3 Ube Industries δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Ube Industries δ-Valerolactone Products Offered
        10.2.5 Ube Industries Recent Development
    10.3 MYJ Chemical
        10.3.1 MYJ Chemical Company Information
        10.3.2 MYJ Chemical Introduction and Business Overview
        10.3.3 MYJ Chemical δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 MYJ Chemical δ-Valerolactone Products Offered
        10.3.5 MYJ Chemical Recent Development
    10.4 Ningbo INNO Pharmchem
        10.4.1 Ningbo INNO Pharmchem Company Information
        10.4.2 Ningbo INNO Pharmchem Introduction and Business Overview
        10.4.3 Ningbo INNO Pharmchem δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Ningbo INNO Pharmchem δ-Valerolactone Products Offered
        10.4.5 Ningbo INNO Pharmchem Recent Development
    10.5 Skylead Pharmaceuticals & Chemicals
        10.5.1 Skylead Pharmaceuticals & Chemicals Company Information
        10.5.2 Skylead Pharmaceuticals & Chemicals Introduction and Business Overview
        10.5.3 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Products Offered
        10.5.5 Skylead Pharmaceuticals & Chemicals Recent Development
    10.6 Penta Manufacturing
        10.6.1 Penta Manufacturing Company Information
        10.6.2 Penta Manufacturing Introduction and Business Overview
        10.6.3 Penta Manufacturing δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Penta Manufacturing δ-Valerolactone Products Offered
        10.6.5 Penta Manufacturing Recent Development
    10.7 Zhejiang Boadge Chemical
        10.7.1 Zhejiang Boadge Chemical Company Information
        10.7.2 Zhejiang Boadge Chemical Introduction and Business Overview
        10.7.3 Zhejiang Boadge Chemical δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Zhejiang Boadge Chemical δ-Valerolactone Products Offered
        10.7.5 Zhejiang Boadge Chemical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 δ-Valerolactone Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers 
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 δ-Valerolactone Industrial Chain Analysis
    11.4 δ-Valerolactone Market Dynamics
        11.4.1 δ-Valerolactone Industry Trends
        11.4.2 δ-Valerolactone Market Drivers
        11.4.3 δ-Valerolactone Market Challenges
        11.4.4 δ-Valerolactone Market Restraints
12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 δ-Valerolactone Distributors
    12.3 δ-Valerolactone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer